Publicaciones en las que colabora con Josep Antoni Ramos-Quiroga (3)

2018

  1. Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: A descriptive analysis

    BMC Psychiatry, Vol. 18, Núm. 1

2014

  1. Expert Recommendation: Contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD)

    Actas Espanolas de Psiquiatria, Vol. 42, pp. 1-16

2012

  1. Genetic bases of attention deficit hyperactivity disorder

    Revista de Neurologia, Vol. 55, Núm. 10, pp. 609-618